Investor’s Delight: Sagimet Biosciences Inc (SGMT) Closes Weak at 5.25, Down -11.62

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

The closing price of Sagimet Biosciences Inc (NASDAQ: SGMT) was $5.25 for the day, down -11.62% from the previous closing price of $5.94. In other words, the price has decreased by -$11.62 from its previous closing price. On the day, 0.82 million shares were traded. SGMT stock price reached its highest trading level at $6.206 during the session, while it also had its lowest trading level at $5.02.

Ratios:

Our analysis of SGMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 38.34 and its Current Ratio is at 38.34. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $30.

On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $12.

Goldman Downgraded its Buy to Neutral on June 28, 2024, whereas the target price for the stock was revised from $23 to $6.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 23 ’24 when Kemble George sold 23,625 shares for $3.17 per share. The transaction valued at 74,830 led to the insider holds 118,693 shares of the business.

Martins Eduardo Bruno sold 8,357 shares of SGMT for $25,910 on Jul 19 ’24. The Chief Medical Officer now owns 81,213 shares after completing the transaction at $3.10 per share. On Jul 19 ’24, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,914 shares for $3.10 each. As a result, the insider received 33,830 and left with 160,506 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 169025328 and an Enterprise Value of -906065. Its current Enterprise Value per Revenue stands at -0.453.

Stock Price History:

Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.39. The 50-Day Moving Average of the stock is 0.12%, while the 200-Day Moving Average is calculated to be 22.45%.

Shares Statistics:

SGMT traded an average of 1.56M shares per day over the past three months and 1040780 shares per day over the past ten days. A total of 30.67M shares are outstanding, with a floating share count of 20.41M. Insiders hold about 36.62% of the company’s shares, while institutions hold 47.17% stake in the company. Shares short for SGMT as of 1730332800 were 4171230 with a Short Ratio of 2.65, compared to 1727654400 on 1971420. Therefore, it implies a Short% of Shares Outstanding of 4171230 and a Short% of Float of 15.479999999999999.

Most Popular